UPDATE 1-Vaccine vial maker Stevanato valued at over $5 bln in NYSE debut - Reuters

9:09am PDT - July 16th, 2021    stock market - Reuters

Shares of Italy's Stevanato Group S.p.A. , which makes glass vials for COVID-19 vaccines and other healthcare products, fell more than 20% in their New York Stock Exchange debut, giving the company a market capitalization of over $5 billion.